THG enters its Q2 earnings release today — July 29 — having gained 5.4% over the past month to $224.15, outpacing nearly every close peer in the P&C insurance space. That strength makes the analyst community's recent pivot to caution the most interesting tension heading into the print.
The Street's direction of travel has turned neutral despite rising price targets. Piper Sandler downgraded THG to Neutral on July 15, and Keefe, Bruyette & Woods cut to Market Perform on July 8 — both firms kept targets in the $220 range, essentially saying the stock has caught up to fair value. Morgan Stanley raised its Equal-Weight target to $225 over the same stretch. The pattern is clear: analysts are lifting numbers to reflect the run, while simultaneously pulling back on conviction. The consensus sits at "hold" with six analysts there and just one outperform, and the factor score for analyst recommendation differential ranks in the 95th percentile — meaning THG is being downgraded more aggressively relative to peers than almost any other name in the universe right now.
Bulls point to a genuine fundamental story. Net investment income is growing as the company redeploys capital into higher-yield assets, General Liability and Excess/Umbrella segments are expanding, and ROE has climbed into the high teens. The EPS surprise factor ranks in the 80th percentile, and the 90-day EPS momentum score sits at the 76th percentile — the company has been consistently beating estimates. Bears counter that loss ratios for accident years 2021–2025 remain above pre-COVID levels, that the underwriting record through 2022–2023 was genuinely poor, and that EPS growth is expected to slow from 2026 into 2027. The stock's trailing P/E has re-rated up 0.39 points over the past 30 days to roughly 11.8x — not stretched, but no longer the obvious value it was.
Short interest tells a benign story on its own. Bears hold about 3.3% of the free float — up 12% over the past month in share terms, but the absolute level is modest. Borrow costs are running at just 0.54%, barely changed from a month ago. Availability is exceptionally loose at roughly 9,500% — meaning the lending pool is almost entirely untapped. There is no squeeze dynamic here. Options positioning, however, has flipped sharply bullish: the put/call ratio has collapsed to 0.19, a near 52-week low, from readings above 3.5 to 5.0 just two weeks ago. That dramatic rotation out of puts suggests options traders have moved decisively to the upside ahead of today's release. The stock has also outrun most peers on the week — up 4.2% versus gains of 1–3% for AFG, AXS, EG, ALL, and CB.
With the CEO and several EVPs having sold shares in late May at prices well below today's level, and with analysts trimming ratings even as targets tick up, today's print will test whether THG's operational momentum — particularly combined ratio improvement and investment income — is strong enough to justify a valuation that has already moved past what most of the Street considers fair.
See the live data behind this article on ORTEX.
Open THG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
